Modular Medical, Inc. (MODD)
USD 0.97
(-6.43%)
USD 0.97
(-6.43%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -17.1 Million USD | -26.48% |
| 2023 | -13.52 Million USD | 4.95% |
| 2022 | -14.8 Million USD | -101.82% |
| 2021 | -7.15 Million USD | -35.41% |
| 2020 | -5.28 Million USD | -106.17% |
| 2019 | -2.56 Million USD | -285.79% |
| 2018 | -664.3 Thousand USD | -629.59% |
| 2017 | - USD | -591.72% |
| 2016 | -13.16 Thousand USD | 18.32% |
| 2015 | -16.11 Thousand USD | -49.6% |
| 2014 | -10.77 Thousand USD | 1.36% |
| 2013 | -10.92 Thousand USD | -14.79% |
| 2012 | -9513.00 USD | -3.7% |
| 2011 | -9174.00 USD | -19.64% |
| 2010 | -7668.00 USD | 18.43% |
| 2009 | -9400.00 USD | -39.96% |
| 2008 | -6716.00 USD | -3.61% |
| 2007 | -6482.00 USD | 27.22% |
| 2006 | -8906.00 USD | 37.67% |
| 2005 | -14.28 Thousand USD | -130.21% |
| 2004 | -6207.00 USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -3.69 Million USD | -9.33% |
| 2024 FY | - USD | -22.12% |
| 2024 Q4 | -4.08 Million USD | 18.74% |
| 2024 Q2 | -4.09 Million USD | -10.89% |
| 2024 Q3 | -5.13 Million USD | -25.49% |
| 2023 FY | - USD | 4.95% |
| 2023 Q1 | -3.47 Million USD | 12.57% |
| 2023 Q4 | -3.57 Million USD | -9.67% |
| 2023 Q3 | -3.25 Million USD | 4.73% |
| 2023 Q2 | -3.41 Million USD | 1.5% |
| 2022 FY | - USD | -101.82% |
| 2022 Q1 | -2.96 Million USD | -75.67% |
| 2022 Q2 | -3.64 Million USD | -23.11% |
| 2022 Q3 | -3.78 Million USD | -3.79% |
| 2022 Q4 | -3.96 Million USD | -4.89% |
| 2021 Q2 | -1.77 Million USD | 4.95% |
| 2021 Q4 | -1.68 Million USD | 7.57% |
| 2021 Q1 | -1.86 Million USD | 1.9% |
| 2021 Q3 | -1.82 Million USD | -2.67% |
| 2021 FY | - USD | -35.41% |
| 2020 FY | - USD | -106.17% |
| 2020 Q1 | -1.13 Million USD | -11.29% |
| 2020 Q2 | -1.14 Million USD | -1.61% |
| 2020 Q3 | -1.12 Million USD | 2.03% |
| 2020 Q4 | -1.9 Million USD | -69.13% |
| 2019 FY | - USD | -285.79% |
| 2019 Q1 | -253.79 Thousand USD | -37.86% |
| 2019 Q2 | -547.18 Thousand USD | -115.6% |
| 2019 Q3 | -745.12 Thousand USD | -36.17% |
| 2019 Q4 | -1.01 Million USD | -36.45% |
| 2018 FY | - USD | -629.59% |
| 2018 Q3 | -260.4 Thousand USD | -47.7% |
| 2018 Q2 | -176.3 Thousand USD | -120.0% |
| 2018 Q1 | -80.13 Thousand USD | -3555.98% |
| 2018 Q4 | -184.09 Thousand USD | 29.31% |
| 2017 Q1 | -1753.00 USD | 18.16% |
| 2017 FY | - USD | -591.72% |
| 2017 Q4 | -2192.00 USD | 12.04% |
| 2017 Q3 | -2492.00 USD | 59.99% |
| 2017 Q2 | -6228.00 USD | -255.28% |
| 2016 Q4 | -2142.00 USD | 11.38% |
| 2016 Q2 | -6851.00 USD | -89.41% |
| 2016 Q1 | -3617.00 USD | 12.14% |
| 2016 Q3 | -2417.00 USD | 64.72% |
| 2016 FY | - USD | 18.32% |
| 2015 Q1 | -1742.00 USD | 18.98% |
| 2015 FY | - USD | -49.6% |
| 2015 Q2 | -4524.00 USD | -159.7% |
| 2015 Q4 | -4117.00 USD | -6.74% |
| 2015 Q3 | -3857.00 USD | 14.74% |
| 2014 Q3 | -2475.00 USD | 43.81% |
| 2014 Q1 | -2050.00 USD | 0.0% |
| 2014 Q2 | -4405.00 USD | -114.88% |
| 2014 Q4 | -2150.00 USD | 13.13% |
| 2014 FY | - USD | 1.36% |
| 2013 Q2 | -4705.00 USD | -248.52% |
| 2013 FY | - USD | -14.79% |
| 2013 Q1 | -1350.00 USD | 32.09% |
| 2013 Q4 | -2050.00 USD | 3.07% |
| 2013 Q3 | -2115.00 USD | 55.05% |
| 2012 Q1 | -2047.00 USD | -20.41% |
| 2012 FY | - USD | -3.7% |
| 2012 Q4 | -1988.00 USD | -5.8% |
| 2012 Q3 | -1879.00 USD | 56.26% |
| 2012 Q2 | -4296.00 USD | -109.87% |
| 2011 Q2 | -3917.00 USD | -360.82% |
| 2011 Q1 | -850.00 USD | 50.29% |
| 2011 FY | - USD | -19.64% |
| 2011 Q4 | -1700.00 USD | -12.58% |
| 2011 Q3 | -1510.00 USD | 61.45% |
| 2010 Q1 | -575.00 USD | 52.08% |
| 2010 FY | - USD | 18.43% |
| 2010 Q4 | -1710.00 USD | -76.11% |
| 2010 Q3 | -971.00 USD | 76.53% |
| 2010 Q2 | -4137.00 USD | -619.48% |
| 2009 Q2 | -6355.00 USD | -531.08% |
| 2009 Q3 | -1270.00 USD | 80.02% |
| 2009 Q4 | -1200.00 USD | 5.51% |
| 2009 FY | - USD | -39.96% |
| 2009 Q1 | -1007.00 USD | -17.37% |
| 2008 Q3 | -940.00 USD | 75.97% |
| 2008 FY | - USD | -3.61% |
| 2008 Q4 | -858.00 USD | 8.72% |
| 2008 Q2 | -3911.00 USD | -6961.4% |
| 2008 Q1 | 57.00 USD | 104.83% |
| 2007 FY | - USD | 27.22% |
| 2007 Q2 | -3567.00 USD | -285.62% |
| 2007 Q3 | -1792.00 USD | 49.76% |
| 2007 Q4 | -1180.00 USD | 34.15% |
| 2007 Q1 | -925.00 USD | 41.05% |
| 2006 Q4 | -1569.00 USD | -10.81% |
| 2006 Q2 | -4996.00 USD | -36.84% |
| 2006 FY | - USD | 37.67% |
| 2006 Q1 | -3651.00 USD | -105.57% |
| 2006 Q3 | -1416.00 USD | 71.66% |
| 2005 FY | - USD | -130.21% |
| 2005 Q3 | -4544.00 USD | -5.23% |
| 2005 Q2 | -4318.00 USD | 0.0% |
| 2005 Q4 | -1776.00 USD | 60.92% |
| 2004 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -26.811% |
| Cerus Corporation | -26.53 Million USD | 35.548% |
| OrthoPediatrics Corp. | -8.38 Million USD | -104.069% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -62.971% |
| Talis Biomedical Corporation | -66.04 Million USD | 74.104% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -2.567% |
| Inogen, Inc. | -45.67 Million USD | 62.558% |
| Spectral AI, Inc. | -12.26 Million USD | -39.48% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 64.139% |
| CVRx, Inc. | -38.73 Million USD | 55.842% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -384.779% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -41.265% |
| Orthofix Medical Inc. | -86.98 Million USD | 80.338% |
| Venus Concept Inc. | -26.11 Million USD | 34.504% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 65.637% |
| Bioventus Inc. | -23.07 Million USD | 25.865% |
| BrainsWay Ltd. | -2.31 Million USD | -640.069% |
| Envoy Medical, Inc. | -18.23 Million USD | 6.223% |
| electroCore, Inc. | -17.76 Million USD | 3.699% |
| IceCure Medical Ltd | -15.25 Million USD | -12.129% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 65.623% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -1.467% |
| MaxCyte, Inc. | -44.12 Million USD | 61.242% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -45.483% |
| Nexalin Technology, Inc. | -5.69 Million USD | -200.472% |
| PAVmed Inc | -75.74 Million USD | 77.419% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 68.185% |
| RxSight, Inc. | -41.03 Million USD | 58.323% |
| Sight Sciences, Inc. | -49.41 Million USD | 65.389% |
| SI-BONE, Inc. | -34.44 Million USD | 50.348% |
| TELA Bio, Inc. | -40.63 Million USD | 57.909% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 70.663% |
| Treace Medical Concepts, Inc. | -39 Million USD | 56.155% |
| LivaNova PLC | 39.01 Million USD | 143.836% |
| 908 Devices Inc. | -34.02 Million USD | 49.734% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 84.535% |
| Nemaura Medical Inc. | -7.28 Million USD | -134.704% |
| NeuroPace, Inc. | -22.83 Million USD | 25.099% |
| LENSAR, Inc. | -8.71 Million USD | -96.27% |
| Apyx Medical Corporation | -18.11 Million USD | 5.571% |
| Cutera, Inc. | -136.56 Million USD | 87.476% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -406.006% |
| BioSig Technologies, Inc. | -28.15 Million USD | 39.245% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 779.769% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 18.514% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 104.459% |
| Axonics, Inc. | 7.77 Million USD | 319.974% |
| Outset Medical, Inc. | -153.78 Million USD | 88.879% |
| IRIDEX Corporation | -7.44 Million USD | -129.632% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 82.565% |
| IRadimed Corporation | 20.8 Million USD | 182.223% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -112.143% |
| INVO Bioscience, Inc. | -6.88 Million USD | -148.589% |
| Telesis Bio, Inc. | -40.49 Million USD | 57.763% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 146.631% |
| Varex Imaging Corporation | 67.2 Million USD | 125.451% |
| Quipt Home Medical Corp. | 44.07 Million USD | 138.808% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -57.341% |
| Pulmonx Corporation | -55.09 Million USD | 68.956% |
| Dynatronics Corporation | -976 Thousand USD | -1652.342% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -18.074% |
| Semler Scientific, Inc. | 23.58 Million USD | 172.504% |
| InMode Ltd. | 196.28 Million USD | 108.713% |
| Bruker Corporation | 599 Million USD | 102.855% |
| Cytosorbents Corporation | -28.81 Million USD | 40.637% |
| DexCom, Inc. | 916.7 Million USD | 101.866% |
| Align Technology, Inc. | 799.03 Million USD | 102.14% |
| Viveve Medical, Inc. | -20.61 Million USD | 17.044% |
| ZimVie Inc. | 91.07 Million USD | 118.779% |
| Movano Inc. | -29.12 Million USD | 41.277% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -287.999% |
| Nexalin Technology, Inc. | -5.69 Million USD | -200.472% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -384.779% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 91.214% |
| Profound Medical Corp. | -27.12 Million USD | 36.944% |
| Insulet Corporation | 323.6 Million USD | 105.285% |
| enVVeno Medical Corporation | -25.01 Million USD | 31.637% |
| Surmodics, Inc. | 1.18 Million USD | 1539.646% |
| iCAD, Inc. | -6.56 Million USD | -160.518% |
| Nuwellis, Inc. | -16.35 Million USD | -4.567% |
| Biotricity, Inc. | -8.82 Million USD | -93.73% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 82.343% |
| Aethlon Medical, Inc. | -11.84 Million USD | -44.34% |
| InspireMD, Inc. | -20.91 Million USD | 18.211% |
| PAVmed Inc. | -75.74 Million USD | 77.419% |
| BIOLASE, Inc. | -15.13 Million USD | -12.973% |
| Beyond Air, Inc. | -59.03 Million USD | 71.027% |
| FONAR Corporation | 28.25 Million USD | 160.538% |
| AxoGen, Inc. | -13.32 Million USD | -28.324% |
| Vivani Medical, Inc. | -26.6 Million USD | 35.722% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 169.692% |
| Inari Medical, Inc. | 7.11 Million USD | 340.447% |
| UFP Technologies, Inc. | 72.74 Million USD | 123.512% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -405.141% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -177.827% |
| Tenon Medical, Inc. | -15.52 Million USD | -10.143% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -12.033% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 58.764% |
| AdaptHealth Corp. | -171.09 Million USD | 90.004% |
| Sintx Technologies, Inc. | -6.6 Million USD | -159.136% |
| NanoVibronix, Inc. | -3.43 Million USD | -397.904% |
| Quanterix Corporation | -38.08 Million USD | 55.096% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -57.341% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 57110.0% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 93.832% |
| TransMedics Group, Inc. | -7.6 Million USD | -124.951% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 21.42% |
| NeuroMetrix, Inc. | -7.09 Million USD | -141.03% |
| Hyperfine, Inc. | -47.06 Million USD | 63.658% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 70.667% |
| Biomerica, Inc. | -5.99 Million USD | -185.383% |
| Bone Biologics Corporation | 479.57 Thousand USD | 3666.305% |
| AVITA Medical, Inc. | -39.56 Million USD | 56.775% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -86.451% |
| Silk Road Medical, Inc | -45.08 Million USD | 62.061% |